Open Access

Distribution of Blastocystis subtypes isolated from humans from an urban community in Rio de Janeiro, Brazil

  • Carolina Valença Barbosa1,
  • Rosemary de Jesus Batista2,
  • Ricardo Pereira Igreja3,
  • Claudia Masini d’Avila Levy1,
  • Heloisa Werneck de Macedo4 and
  • Helena Lúcia Carneiro Santos1Email author
Parasites & Vectors201710:518

https://doi.org/10.1186/s13071-017-2458-0

Received: 10 January 2017

Accepted: 6 October 2017

Published: 25 October 2017

Abstract

Background

Blastocystis is a cosmopolitan protist parasite found in the human gastrointestinal tract and is highly prevalent in developing countries. Recent molecular studies have revealed extensive genetic diversity, which has been classified into different subtypes (STs) based on sequence analysis of small subunit ribosomal RNA gene. Blastocystis is one of the most common fecal parasites in Brazil, but the diversity of subtypes remains unknown in the country. This study aimed to determine the distribution of Blastocystis STs in an urban community in Duque de Caxias, Rio de Janeiro, Brazil.

Methods

A total of 64 stool samples positive for Blastocystis in Pavlova’s medium were subtyped by PCR and sequenced using primers targeting the small subunit rRNA gene, in addition to phylogenetic analysis and subtype-specific PCR using sequence-tagged-site (STS) primers.

Results

Endolimax nana (14%), Entamoeba complex (10.5%), Taenia sp. (0.6%), Trichuris trichiura (1.3%) and Enterobius vermicularis (1.3%) were detected in Blastocystis-positive samples. Of the 64 samples tested by PCR/DNA sequencing, 55 were identified as ST1 (42%), ST3 (49%), ST2 (7%) and ST4 (2%), and the presence of mixed ST (ST1 + ST3) infection was detected in nine samples (14%).

Conclusions

DNA sequencing and phylogenetic analysis of Brazilian Blastocystis isolates identified four different subtypes. To our knowledge, this study provided the first genetic characterization of Blastocystis subtypes in an urban area of Rio de Janeiro, Brazil. We also identified ST4 for the first time in Brazil. Further studies are necessary to determine the distribution of STs across human populations in Rio de Janeiro.

Keywords

Blastocystis PCRSubtypesEpidemiology

Background

Blastocystis spp. are strictly anaerobic unicellular organisms that inhabit the gastrointestinal tract of humans as well as other mammals, birds, amphibians, reptiles, fish, arthropods and annelids [19]. Blastocystis is a cosmopolitan enteric protist estimated to infect over one billion people worldwide [10]. However, its prevalence rates vary widely between countries and between regions within the same country [11, 12], possibly reaching 30% in industrialized countries and 30–76% in developing nations [1318]. In the latter, high prevalence rates may be directly related to educational deficits, poor socioeconomic status, and sanitary conditions [1922]. Nevertheless, high rates of infection are also observed in developed countries, especially among individuals who work with animals [6, 7, 23]. Previous studies have reported that the transmission of Blastocystis is fecal-oral, and as a result the protist was included in the Water Sanitation and Health program of the World Health Organization [24].

Although Blastocystis is an emerging intestinal parasite [25], its pathogenic potential remains unclear [24]. Diagnostic limitations, extensive genetic diversity, poor understanding of the host-parasite relationship, and the lack of an experimental model represent major bottlenecks in elucidating the clinical significance and pathogenesis of Blastocystis. After infection (blastocystosis), not all persons develop the clinical disease, for which common symptoms include chronic or acute diarrhea, abdominal pain, flatulence, anorexia, nausea and vomiting [2628]. One case of enteroinvasive blastocystosis diagnosed by histopathological analysis of biopsies showed Blastocystis in ulcers in the cecum, transverse colon and rectum of an immunocompetent individual, indicating that the parasite has invasive potential [29]. In addition, a case of appendicitis associated with appendix lumen obstruction caused by Blastocystis has also been reported [30]. Blastocystis subtype 3 (ST3) was detected in the appendix, recto-uterine pouch, and peritoneal fluid of a nineyear-old child [31] and in splenic cysts of an immunocompetent woman [32]. Other studies have reported extraintestinal manifestations including arthritis (with full resolution of clinical symptoms after metronidazole treatment) and recurrent episodes of arthritis in immunocompetent individuals [33]. Additionally, several studies suggest an association of Blastocystis with urticaria and skin lesions in immunocompetent individuals [34, 35]. These findings provide strong evidence of the ability of Blastocystis to migrate to extraintestinal sites and of its pathogenic potential. Moreover, some epidemiological surveys have suggested a strong association between irritable bowel syndrome (IBS) and Blastocystis, but this association has been questioned [36, 37].

Molecular analyses of the small-subunit ribosomal RNA have revealed extensive genetic diversity in the species. To date, 17 subtypes have been described (ST1-ST17), nine of which (ST1-ST9) are found both in humans and animals, while the others are exclusively found in animals [8, 38]. These subtypes have not been characterized as species, have low host specificity, and were isolated from humans and various animal hosts [39]. In humans, the most frequently detected subtype is ST3, followed by ST1, ST2, and ST4, whereas ST5-ST9 are rarely found [9, 40]. Genetic diversity varies dramatically among Blastocystis subtypes, which are not only separated by significant genetic distance [7, 39] but also differ in levels of intra-subtype variation [41]. Thathaisong et al. [42] detected polymorphisms in Blastocystis ST1 and created ST1/variant, while Melloni et al. [43] observed substantial intra-ST diversity in ST3 isolates and genetic homogeneity in ST4 isolates.

So far, studies have revealed the existence of genetic variability [4447]. However, studies on Blastocystis diversity remain scarce in Brazil, where only three studies have been conducted to date [14, 48, 49]. To address this shortcoming, systematic studies focused on characterizing different isolates are necessary. In this study we report the molecular identification of four subtypes of Blastocystis in a Brazilian population. This study is the first to thoroughly investigate the diversity of Blastocystis subtypes in an urban community in Rio de Janeiro, Brazil. Our findings may be relevant to identifying sources of infection and potential routes of transmission of the parasite.

Methods

A coproparasitological study was conducted at the Center for Psychosocial Care (CAPS), a day-care hospital for the mentally ill in Duque de Caxias, Rio de Janeiro, Brazil.

Participation was voluntary and people could withdraw from the study at any time. To guarantee anonymity, each study participant was given a unique identification number. At the end of the study, all participants identified with enteric parasitic pathogens received proper antiparasitic drugs for treatment. Treatment was not offered to individuals infected with Blastocystis, because its pathogenic potential is still a topic of debate.

After written consent was obtained, fecal material from each participant was collected in a flask and transported to the laboratory. Unpreserved stool samples were requested and collected. A total of 180 unpreserved stool samples were collected at home from non-selected patients (n = 80) and their family members (n = 100), and kept at 4 °C and transported in ice packs to the Parasitology Laboratory at Oswaldo Cruz Foundation. Fresh unpreserved stool samples were fractionated into two aliquots upon receipt.

For parasitological analysis, one aliquot was processed using a spontaneous sedimentation technique (the Lutz technique or the Hoffman, Pons and Janer technique). Stool samples diluted in water were filtered through a gauze strip into a conical cup and subsequently submitted to sedimentation in tap water for 2 h [50]. The concentrated sample was analyzed by wet mounts and stained through an iodine staining procedure. In this study, we did not search for viruses or bacteria.

Direct cultivation of Blastocystis from the aliquot of stool samples was performed using Pavlova’s medium (1.29 g/l of sodium phosphate dibasic, 0.42 g/l of potassium phosphate monobasic, 7.27 g/l of sodium chloride and 1.46 g/l of yeast extract) supplemented with 10% adult bovine serum (ABS) and penicillin-streptomycin (1000 IU/ml and 500 μg/ml, respectively) and incubated at 37 °C [51]. Screening of Blastocystis cultures was performed using a standard light microscopy in the first seven days of incubation. When typical forms of the parasite were observed, Blastocystis culture aliquots were frozen at -20 °C until used for DNA extraction.

Molecular characterization

Total DNA of each isolate was extracted from each culture of Blastocystis suspension using the Qiamp DNA Stool Mini Kit (Qiagen, Valencia, CA, USA) according to manufacturer’s recommendations. DNA was stored at -20 °C until use. To amplify segments from an approximately 500 bp fragment of genus-specific small subunit ribosomal DNA (SSU rDNA), we used the following primers: forward Blast 505-532 (5′-GGA GGT AGT GAC AAT AAA TC-3′) [52] and reverse Blast 998-1017 (5′-TGC TTT CGC ACT TGT TCA TC-3′), following the protocol described by Santin et al. [8]. The PCR reaction was performed in a final volume of 50 μl and each reaction contained 100 mM of Tris-HCl (pH 9.0), 500 mM of KCl, 1.5 mM of MgCl2, 200 μM of each dATP, dGTP, dCTP, and dTTP; 0.2 μM of primer; 1.5 U of Taq DNA polymerase (Invitrogen Life Technologies, Carlsbad, CA, USA), 0.05% of bovine serum albumin (BSA); and 5 μl of the DNA sample. Cycle conditions were an initial activation step at 95 °C for 5 min, followed by 35 cycles at 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 2 min, with a final extension step at 72 °C for 7 min. PCR amplification reactions were performed in a Veriti™ 96-well thermal cycler (AB Applied Biosystems, Foster City, CA, USA). PCR products were electrophoresed in 1.5% agarose gels in a tris-borate EDTA buffer, stained with Gelred (Biotium Inc., Hayward, CA, USA), and photographed under UV transillumination. Amplicons were purified using the Wizard® SV gel and PCR Clean-Up System kit (Promega, Madison, WI, USA) and sequenced in both directions using the PCR primers. DNA cycle sequencing reactions were performed using the BigDye® Terminator v.3.1 Cycle Sequencing Kit (Applied Biosystems) and loaded in the ABI 3730 Sequencing Platform. Bi-directional sequences were assembled and edited using SeqMan (DNASTAR software package, DNASTAR Inc., Madison, WI, USA). DNA sequences of Blastocystis subtypes were downloaded from GenBank and a multiple sequence alignment was performed using the ClustalW algorithm of MEGA software version 6.0 [53]. Bayesian Inference (BI), Maximum Likelihood (ML), and Neighbor-joining analyses of SSU rDNA data were conducted to explore the relationships between taxa using MrBayes [54], PHYML [55] and MEGA software [53], respectively. Nucleotide substitution models were chosen based on the Akaike Information Criterion in jModelTest [56] and MrModeltest [57]. ML analysis was conducted using the Hasegawa-Kishino-Yanov Model with gamma distribution (HKY + G) [58] with four parameters and unequal base frequencies including rate variation among sites (-lnL = 24,599.056), which was predicted as the best model of nucleotide substitutions by the Akaike Information Criterion (AIC). For Bayesian analysis, the HKY + G model was determined by the Bayesian Information Criterion (BIC) as the best-fit substitution model. Proteromonas lacerate (U37108) was used as an out-group [59, 60].

Subtype sequences with mixed traces indicative of mixed infections were analyzed by PCR using subtype-specific sequence-tagged-site (STS) primers (Table 1), according to Yoshikawa et al. [61].
Table 1

Sequence-tagged site (STS) primer sets used in this study targeting SSU rRNA gene of Blastocystis

Primer pair

Target subtype

Primer type

Sequence (5′-3′)

SB83

ST1

F

GAAGGACTCTCTGACGATGA

  

R

GTCCAAATGAAAGGCAGC

SB340

ST2

F

TGTTCTTGTGTCTTCTCAGCTC

  

R

TTCTTTCACACTCCCGTCAT

SB227

ST3

F

TAGGATTTGGTGTTTGGAGA

  

R

TTAGAAGTGAAGGAGATGGAAG

SB337

ST4

F

GTCTTTCCCTGTCTATTCTGCA

  

R

AATTCGGTCTGCTTCTTCTG

SB336

ST5

F

GTGGGTAGAGGAAGGAAAACA

  

R

AGAACAAGTCGATGAAGTGAGAT

SB332

ST6

F

GCATCCAGACTACTATCAACATT

  

R

CCATTTTCAGACAACCACTTA

SB155

ST7

F

ATCAGCCTACAATCTCCTC

  

R

ATCGCCACTTCTCCAAT

Results

A total of 180 participants aged 1–85 years (80 patients and 100 patients’ family members) provided adequate stool samples for the study; 105 (58.3%) were male (mean age: 52 years) and 75 (41.7%) were female (mean age: 48 years). Overall, based on light microscopy examination, 82 (45%) participants were found to be infected with one or more species of intestinal parasites. Of the 180 samples tested by the culture method for the presence of Blastocystis, 64 (35.5%) were positive, whereas microscopy examination was less effective in detecting Blastocystis, with only 49 (27%) samples showing positive results. The frequency of Blastocystis infections was 32.5% (26/80) among patients and 38% (38/100) in family members. Among the 64 Blastocystis-positive participants, 18.3% (33/180) of individuals (14 patients and 19 family members) presented poly-parasitism. Endolimax nana (14%), Entamoeba complex (10.5%), Taenia sp. (0.6%), Trichuris trichiura (1.3%) and Enterobius vermicularis (1.3%) were detected in the Blastocystis-positive samples. Of the 31 participants singly infected with Blastocystis, only five family members reported symptoms: two individuals reported intermittent episodes of diarrhea, while the other three respectively presented flatulence, bloating and abdominal discomfort.

Typing of Blastocystis

APCR amplicon of approximately 500 bp of the SSU rDNA was successfully generated in all 64 samples. DNA sequencing revealed single-subtype infection in 55 isolates. Those 55 sequences showed a high identity (97–100%) to the reference sequences previously published by GenBank, and were identified as four distinct subtypes: ST1, ST2, ST3 and ST4. Blastocystis ST3 was the most prevalent subtype, followed by ST1, ST2 and ST4 (Table 2). In the remaining nine samples, sequence chromatogram analysis revealed the presence of double traces and mixed-subtype infection, and accordingly a PCR with subtype-specific sequence-tagged-site (STS) primers revealed the presence of both ST1 and ST3 (Table 2). In relation to the distribution of reported symptoms, ST2 was found in two family members with intermittent diarrheal episodes, whereas ST1, ST2 and ST3 were identified in three relatives of patients who respectively reported flatulence, bloating and abdominal discomfort.
Table 2

Blastocystis subtypes identified in the present study

Subtype

No. of isolates

Isolate code and GenBank accession number

ST1

23

RTDC1 (KU892242); RTDC4 (KU892241); RTDC5 (KU892222); RTDC8 (KU892243); RTDC17 (KU892244); RTDC27 (KU892225); RTDC29 (KU892233); RTDC32 (KU892227); RTDC35 (KU892237); RTDC36 (KU892229); RTDC37 (KU892235); RTDC38 (KU892236); RTDC39 (KU892230); RTDC40 (KU892238); RTDC41 (KU892231); RTDC42 (KU892240); RTDC49 (KU892232); RTDC50 (KU892226); RTDC52 (KU892239); RTDC55 (KU892234); RTDC56 (KU892228); RTDC60 (KU892223); RTDC66 (KU892224)

ST2

4

RTDC44 (KU892245); RTDC45 (KU892246); RTDC 67 (KU892247); RTDC69 (KU892248)

ST3

27

RTDC2 (KU892249); RTDC 3 (KU892250); RTDC6 (KU892251); RTDC10 (KU892252); RTDC 12 (KU892253); RTDC20 (KU892254); RTDC 22 (KU892255); RTDC23 (KU892256); RTDC 24 (KU892257); RTDC25 (KU892258); RTDC 26 (KU892259); RTDC28 (KU892260); RTDC 30 (KU892261); RTDC31 (KU892262); RTDC 33 (KU892263); RTDC34 (KU892264); RTDC 43 (KU892265); RTDC51 (KU892266); RTDC 54 (KU892267); RTDC57 (KU892268); RTDC 58 (KU892269); RTDC59 (KU892270); RTDC 61 (KU892271); RTDC62 (KU892272); RTDC 63 (KU892273); RTDC64 (KU892274); RTDC 65 (KU892275)

ST4

1

RTDC9 (KU892276)

ST1- ST3a

9

RTDC13; RTDC15; RTDC18; RTDC21; RTDC47; RTDC48; RTDC53; RTDC68; RTDC70

aSubtype-specific sequence-tagged-site (STS) primers

Phylogenetic analysis of 21 reference sequences using NJ, ML and BI analyses clustered Blastocystis subtypes into four monophyletic groups (Fig. 1). Twenty-three isolates clustered with the ST1 reference sequence, four formed a distinct clade with ST2, 27 clustered with ST3, and one clustered with ST4. Intra-strain variation was observed among distinct subtypes: ST1 and ST3 isolates formed small clades within each subtype, indicating extensive genetic variability in the two strains. The posterior probability support in BI analyses had overall higher values than the bootstrap support in ML across the whole tree. Phylogenetic analyses using ML and BI (Fig. 1) and NJ (not shown) indicated that ST1 and ST2 share a common ancestor. The trees also showed that ST6, ST9 and ST7 are related, and that ST8 and ST4 are closely related.
Fig. 1

Phylogenetic tree for Blastocystis based on SSU rRNA gene sequences. Bayesian Inference (BI) tree reconstructed using the newly generated and GenBank-retrieved partial SSU rRNA gene sequences for Blastocysts. The first number associated with each node represents the Maximum Likelihood (ML) bootstrap value followed by the Bayesian Inference posterior probabilities. Black triangles represent Brazilian samples. The scale-bar indicates the expected number of substitutions per site

Discussion

Blastocystis is one of the most prevalent unicellular protists found in human fecal specimens [10]. In our study, ST3 was the most prevalent subtype, followed by ST1, ST2, and ST4. In addition, mixed infections were detected in 14% of the samples, similar to the prevalence reported in other countries, which ranged between 2.6–14.3% [6, 12, 19, 46, 49, 6264]. According to Alfellani et al. [9], single infections are typically reported, whereas mixed infections have been reported in less than half of the studies, at an overall prevalence of only 6%, suggesting a possible under estimation compromising the validity of results and their epidemiological interpretation. Our phylogenetic trees revealed four well-defined clades that grouped isolates into four different subtypes, bearing similarity to those reported in previous studies. In Brazil, even though only three studies have published ST data, the geographical distribution of Blastocystis subtypes varies across regions. ST1 was the most prevalent subtype (followed by ST2 and ST3) among an indigenous population from Mato Grosso, Brazil, whereas a study conducted in two small fishing villages situated along the Tietê River in the state of São Paulo, Brazil found a higher incidence of ST3 isolates, followed by ST1 [14, 48, 49].

Globally, subtypes ST1-ST4 have been identified as the most common subtypes in humans [6, 9, 19, 36, 61, 6570]. Even though it has been suggested that ST3 is the only subtype of human origin [11, 60, 70], it has been detected in several other hosts including pigs, cattle, and non-human primates [3, 9, 65, 71, 72]. Several studies across the world have identified ST3 as the predominant Blastocystis subtype [9, 12, 18, 19, 67, 69, 7280]. Our study identified ST4 in one only sample. This contrasts with previous studies showing that ST4 is common in European and African populations [9, 38, 64, 8185]. Rodents have been proposed as the reservoir host of this subtype [58, 8688]. In Colombia, ST4 has been identified in a few humans and non-human primates [85, 86]. However, the molecular epidemiology of Blastocystis is incompletely known in other South American countries. To better understand the genetic diversity and determine the prevalence of Blastocystis subtypes in South America, further research with larger sample sizes is required.

After ST3, ST1 was the most frequent subtype detected in our study. ST1 has low specificity and is found in a wide range of animals, including dogs, chickens, cattle, pigs and non-human primates [3, 63]. Some studies have suggested that ST1 is linked to zoonotic transmission [89, 90]. Blastocystis is transmitted by the fecal-oral route [1] and several studies have suggested that contaminated water may be a source of Blastocystis infections [19, 20, 88, 91, 92]. A study conducted in China reported a high infection rate (32.6%) and found that inadequate water intake was a predictor of Blastocystis infection [19]. Also, Blastocystis has been detected in samples of soil and drinking water [93]. Overall, many human settlements are characterized by poor hygiene habits, extensive interpersonal contact and increased dependency on care, which provide favorable conditions for the circulation and transmission of parasites and increased susceptibility to parasitic infections. This was revealed by reports of enteric parasitic infections in mental institutions, which indicate that rates of intestinal parasitic infections are higher among institutionalized persons than in the general population, even in developed countries [94]. It should be noted that we analyzed unpreserved stool samples from non-selected adults and identified Blastocystis in 46% of family members, compared to a lower figure of 32.5% among institutionalized patients. Therefore, at least in our study population, transmission through cyst-contaminated water appears to be more common than transmission at the care center [87, 88, 90]. The presence of intestinal parasites in the population highlights the need for a more comprehensive epidemiological study in the region to support public policies aimed at educating the public about intestinal parasite prevention. Over the last few years, scientific interest has increased tremendously with respect to the clinical relevance of Blastocystis infection and molecular epidemiology.

We should note that the source of DNA (feces vs culture) used in PCR may in principle imply a bias in subtyping. We used DNA from cultured Blastocsytis, and it is possible that parasite culture could have led to a selection of subtypes of Blastocystis. However, this was not observed in a previous study by Stensvold et al. [38] which involved mixed infections. The authors stated that xenic in vitro culture (XIVC) has very little or no impact on subtype distribution or variation within a given specimen. Moreover, the authors recommended that short-term XIVC should be used for cost-effective screening of Blastocystis infection from fresh fecal specimens, to generate valid prevalence estimates and to identify isolates. When PCR is based on DNA extracted from feces, the consequence may be false-negative results or decreased PCR efficiency due to a series of factors, including low amount of template DNA in the test sample, inadequate removal of polymerase inhibitors and poor DNA recovery after extraction and purification steps. As a reasonable solution to the presence of inhibitors or degraded target DNA in samples, constitutive genes may be used in parallel assays to evaluate the integrity of the DNA template. PCR is such a powerful tool that even a single molecule of template can be amplified. However, it is difficult to amplify rare templates when they are mixed with similar, but more abundant, templates sharing amplification primers. Nonetheless, no study has evaluated the sensitivity range of PCR using a panel of mixed Blastocystis infection samples (multi-ST infections). Moreover, little is known about ST gene targets and how conserved they are both within, and between, subtypes. Had DNA from feces been available for each of the Blastocystis samples in our study, it would have been possible to answer some of these important questions.

It has been suggested that pathogenicity may be related to specific Blastocystis subtypes, but this association is still inconclusive and often contradictory. Many previous reports on the potential pathogenicity of Blastocystis have been limited by a lack of definition of symptoms and more comprehensive investigations able to exclude other infectious agents of diarrhea [91, 95, 96]. Unfortunately, we could not estimate correlations between subtype distributions and symptoms due to the high proportion of asymptomatic individuals, in addition to the fact that individuals had symptoms that could be attributed to other causes (co-infections with pathogenic and commensal intestinal protozoans as well as helminths). In symptomatic individuals not infected by any other protozoans or helminths, the symptoms of Blastocystis infection were intermittent episodes of diarrhea, flatulence (in the case of ST2 infection), and flatulence, bloating, and abdominal discomfort but no diarrhea (in the case of ST1, ST2 and ST3). However, other possible causes of clinical symptoms must be considered, such as viral and bacterial infections not evaluated in this study.

Conclusions

To our knowledge, we conducted the first molecular study of human Blastocystis infection in Rio de Janeiro, Brazil. Blastocystis isolates were highly genetically divergent. Of the subtypes identified, ST3 was the most common, followed by ST1, ST2 and ST4 (ST4 was identified for the first time in Brazil). However, these results cannot be generalized to the entire Rio de Janeiro population. Further studies are required to determine the distribution of STs in the general population. Nonetheless, our study is a contribution to the understanding of the molecular epidemiology, transmission patterns and genetic diversity of Blastocystis at a regional and global scale.

Abbreviations

AIC: 

Akaike Information Criterion

BI: 

Bayesian Inference

BIC: 

Bayesian Information Criterion

ML: 

Maximum Likelihood

MLST: 

multilocus sequence typing

NJ: 

Neighbor-joining

SSU rDNA: 

small subunit of the ribosomal RNA gene

ST: 

subtype

Declarations

Acknowledgments

The authors would like to thank the DNA Sequencing PDTIS/FIOCRUZ platform facilities and we also gratefully acknowledge the dedicated efforts of the Center for Psychosocial Care (CAPS) staff who participated actively in the study, particularly Nilzete de Araújo Ribeiro Costa.

Funding

This study was supported by Carlos Chagas Filho Research Foundation of State of Rio de Janeiro (Faperj), the National Council for Scientific and Technological Development (CNPq) and Oswaldo Cruz Foundation (PAPES-VI/FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Availability of data and materials

The data sets supporting the conclusions of this article are included within the article. All sequence data that support the findings of this study have been deposited in the GenBank database under the accession numbers: KU892222–KU892276.

Authors’ contributions

SHLC and MHW conceived and designed the study. SHLC and BRJ obtained the samples and conducted the in vitro cultivation and microscopy examination. BVC was responsible for the molecular analyses and SHLC and IR data analysis and interpretation. BVC, LDCM and HLCS prepared the first draft of the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Prior to data collection, the study protocol was reviewed and approved by the Human Ethics Committee at Oswaldo Cruz Foundation (protocol number. 632/11). Study participants (patients and their family members) were informed about the study’s aims, potential risks and benefits. Participants provided written informed consent followed by signatures of two external witnesses. Individuals unable to provide consent were represented by their caregivers, relatives or legal tutors.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Laboratório de Estudos Integrados em Protozoologia, Instituto Oswaldo Cruz/FIOCRUZ
(2)
Departamento de Ginecologia e Obstetrícia, IFF/Fiocruz, Rio de Janeiro
(3)
Departamento de Medicina Preventiva da Faculdade de Medicina da UFRJ
(4)
Laboratório de Parasitologia do Departamento de Patologia, Hospital Universitário Antônio Pedro/Universidade Federal Fluminense

References

  1. Stenzel D, Boreham P. Blastocystis hominis revisited. Clin Microbiol Rev. 1996;9:563–84.PubMedPubMed CentralGoogle Scholar
  2. Belova LM, Krylov MV. [The distribution of Blastocystis according to different systematic groups of hosts.] Parazitologia. 1998;32:268–76. (In Russian).Google Scholar
  3. Abe N. Molecular and phylogenetic analysis of Blastocystis isolates from various hosts. Vet Parasitol. 2004;120:235–42.View ArticlePubMedGoogle Scholar
  4. Yoshikawa H, Morimoto K, Wu Z, Singh M, Hashimoto T. Problems in speciation in the genus Blastocystis. Trends Parasitol. 2004;20:251–5.View ArticlePubMedGoogle Scholar
  5. Yoshikawa H, Wu Z, Hashimoto T, Geok-Choo N, Tan KS. Ultrastructural and phylogenetic studies on Blastocystis isolates from cochroaches. J Eukaryot Microbiol. 2007;54:33–7.View ArticlePubMedGoogle Scholar
  6. Stensvold CR, Lewis HC, Hammerum AM, Porsbo LJ, Nielsen SS, Olsen KE, et al. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect. 2009;137:1655–63.View ArticlePubMedGoogle Scholar
  7. Parkar U, Traub RJ, Vitali S, Elliot A, Levecke B, Robertson I, et al. Molecular characterization of Blastocystis isolates from zoo animals and their animal-keepers. Vet Parasitol. 2010;169:8–17.View ArticlePubMedGoogle Scholar
  8. Santin M, Gomez-Munoz MT, Solano-Aquilar G, Fayer R. Development of a new PCR protocol to detect and subtype Blastocystis spp. from humans and animals. Parasitol Res. 2011;109:205–12.View ArticlePubMedGoogle Scholar
  9. Alfellani MA, Taner-Mulla D, Jacob AS, Imeede CA, Yoshikawa H, Stensvold CR, Clark CG. Genetic diversity of Blastocystis in livestock and zoo animals. Protist. 2013;164:497–509.View ArticlePubMedGoogle Scholar
  10. Scanlan PD, Stensvold CR. Blastocystis: getting to grips with our guileful guest. Trends Parasitol. 2013;29:523–9.View ArticlePubMedGoogle Scholar
  11. Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev. 2008;21:639–65.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Souppart L, Sanciu G, Cian A, Wawrzyniak I, Delbac F, Capron M, et al. Molecular epidemiology of human Blastocystis isolates in France. Parasitol Res. 2009;105:413–21.View ArticlePubMedGoogle Scholar
  13. Scanlan PD, Stensvold CR, Rajilic-Stojanovi M, Heilig HGHJ, De Vos WM, O’Toole PW, Cotter PD. The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol. 2014;90:326–30.View ArticlePubMedGoogle Scholar
  14. David ÉB, Guimarães S, de Oliveira AP, Goulart de Oliveira-Sequeira TC, Nogueira Bittencourt G, Moraes Nardi AR, et al. Molecular characterization of intestinal protozoa in two poor communities in the state of São Paulo, Brazil. Parasit Vectors. 2015;8:103.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Abu-Madi M, Aly M, Behnke JM, Clark CG, Balkhy H. The distribution of Blastocystis subtypes in isolates from Qatar. Parasit Vectors. 2015;8:465.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Angal L, Mahmud R, Samin S, Yap NJ, Ngui R, Amir A, et al. Determining intestinal parasitic infections (IPIs) in inmates from Kajang prison, Selangor, Malaysia for improved prison management. BMC Infect Dis. 2015;15:467.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Pipatsatitpong D, Leelayoova S, Mungthin M, Aunpad R, Naaglor T, Rangsin R. Prevalence and risk factors for Blastocystis infection among children and caregivers in a child care center, Bangkok, Thailand. Am J Trop Med Hyg. 2015;93:310–5.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Pandey PK, Verma P, Marathe N, Shetty S, Bavdekar A, Patole MS, et al. Prevalence and subtype analysis of Blastocystis in healthy Indian individuals. Infect Genet Evol. 2015;31:296–9.View ArticlePubMedGoogle Scholar
  19. Li LH, Zhang XP, Lv S, Zhang L, Yoshikawa H, Wu Z, et al. Cross-sectional surveys and subtype classification of human Blastocystis isolates from four epidemiological settings in China. Parasitol Res. 2007;102:83–90.View ArticlePubMedGoogle Scholar
  20. Leelayoova S, Siripattanapipong S, Thathaisong U, Naaglor T, Taamasri P, Piyaraj P, Mungthin M. Drinking water: a possible source of Blastocystis spp. subtype 1 infection in schoolchildren of a rural community in central Thailand. Am J Trop Med Hyg. 2008;79:401–6.PubMedGoogle Scholar
  21. Lee L, Chye T, Karmacharya B, Govind S. Blastocystis sp: waterborne zoonotic organism, a possibility? Parasit Vectors. 2012;5:130.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Nagel R, Cuttell L, Stensvold C, Mills P, Bielefeldt-Ohmann H, Traub R. Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. Intern Med J. 2012;42:1187–95.View ArticlePubMedGoogle Scholar
  23. Rajah Salim H, Suresh Kumar G, Vellayan S, Mak JW, Khairul Anuar A, Init I, et al. Blastocystis in animal handlers. Parasitol Res. 1999;85:1032–3.View ArticlePubMedGoogle Scholar
  24. WHO. Guidelines for drinking-water quality (3rd edition, incorporating first and second addenda). Geneva: World Health Organization; 2008.Google Scholar
  25. Turkeltaub JA, McCarty TR, Hotez PJ. The intestinal protozoa. Curr Opin Gastroenterol. 2015;31:38–44.View ArticlePubMedGoogle Scholar
  26. Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R. Vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome. Br J Biomed Sci. 2004;61:75–7.View ArticlePubMedGoogle Scholar
  27. Kaya S, Cetin ES, Aridogan BC, Arikan S, Demirci M. Pathogenicity of Blastocystis hominis, a clinical reevaluation. Turkiye Parazitol Derg. 2007;31:184–7.Google Scholar
  28. Hussein EM, Hussein AM, Eida MM, Atwa MM. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res. 2008;102:853–60.View ArticlePubMedGoogle Scholar
  29. Janarthanan S, Khoury N, Antak F. An unusual case of invasive Blastocystis hominis infection. Endoscopy. 2011;43:E185–6.View ArticlePubMedGoogle Scholar
  30. Lintong PM, Sambuaga MK, Tambajong EH. Acute suppurative appendicitis with Blastocystis hominis. Asian Pac J Trop Dis. 2012;2:965–8.View ArticleGoogle Scholar
  31. Frealle E, El Safadi D, Cian A, Aubry E, Certad G, Osman M, et al. Acute Blastocystis-associated appendicular peritonitis in a child, Casablanca, Morocco. Emerg Infect Dis. 2015;21:91–4.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Santos HLC, Sodré C, de Macedo HW. Blastocystis sp. in splenic cysts: causative agent or accidental association? A unique case report. Parasit Vectors. 2014;7:207.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Lee MG, Rawlins SC, Didier M, DeCeulaer K. Infective arthritis due to Blastocystis hominis. Ann Rheum Dis. 1990;49:192–3.Google Scholar
  34. Verma R, Delfanian K. Blastocystis hominis associated acute urticaria. Am J Med Sci. 2013;346:80–1.View ArticlePubMedGoogle Scholar
  35. Bálint A, Dóczi I, Bereczki L, Gyulai R, Szűcs M, Farkas K, et al. Do not forget the stool examination! - cutaneous and gastrointestinal manifestations of Blastocystis sp. infection. Parasitol Res. 2014;113:1585–90.View ArticlePubMedGoogle Scholar
  36. Boorom KF, Smith H, Nimri L, Viscogliosi E, Spanakos G, Parkar U, et al. Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit Vectors. 2008;1:40.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Poirier P, Wawrzyniak I, Vivares C, Delbac F, El Alaoui H. New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog. 2012;8:e1002545.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Stensvold CR, Suresh GK, Tan KSW, Thompson RCA, Traub RJ, Viscogliosi E, et al. Detecting Blastocystis by parasitological and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis. 2007;59:303–7.View ArticlePubMedGoogle Scholar
  39. Rivera WL. Phylogenetic analysis of Blastocystis isolates from animal and human hosts in the Philippines. Vet Parasitol. 2008;156:178–82.View ArticlePubMedGoogle Scholar
  40. Stensvold CR, Alfellani MA, Nørskov-Lauritsen S, Prip K, Victory EL, Maddox C, et al. Subtype distribution of Blastocystis isolates from synanthropic and zoo animals and identification of a new subtype. Int J Parasitol. 2009;39:473–9.View ArticlePubMedGoogle Scholar
  41. Stensvold CR, Alfellani M, Clark CG. Levels of genetic diversity vary dramatically between Blastocystis subtypes. Infect Genet Evol. 2012;12:263–73.View ArticlePubMedGoogle Scholar
  42. Thathaisong U, Siripattanapipong S, Mungthin M, Pipatsatitpong D, Tan-Ariya P, Naaglor T, Leelayoova S. Identification of Blastocystis subtype 1 variants in the home for girls, Bangkok, Thailand. Am J Trop Med Hyg. 2013;88:352–8.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Meloni D, Poirier P, Mantini C, Noël C, Gantois N, Wawrzyniak I, et al. Mixed human intra- and inter-subtype infections with the parasite Blastocystis sp. Parasitol Int. 2012;61:719–22.View ArticlePubMedGoogle Scholar
  44. Dagci H, Kurt O, Demirel M, Mandiracioglu A, Aydemir S, Saz U, et al. Epidemiological and diagnostic features of Blastocystis infection in symptomatic patients in Izmir province, Turkey. Iran J Parasitol. 2014;9:519–29.PubMedPubMed CentralGoogle Scholar
  45. El Safadi D, Gaayeb L, Meloni D, Cian A, Poirier P, Wawrzyniak I, et al. Children of Senegal River basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis. 2014;14:164.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Osman M, Bories J, El Safadi D, Poirel MT, Gantois N, Benamrouz-Vanneste S, et al. Prevalence and genetic diversity of the intestinal parasites Blastocystis sp. and Cryptosporidium spp. in household dogs in France and evaluation of zoonotic transmission risk. Vet Parasitol. 2015;214:167–70.View ArticlePubMedGoogle Scholar
  47. Mattiucci S, Crisafi B, Gabrielli S, Paoletti M, Cancrini G. Molecular epidemiology and genetic diversity of Blastocystis infection in humans in Italy. Epidemiol Infect. 2016;144:635–46.View ArticlePubMedGoogle Scholar
  48. Malheiros AF, Stensvold CR, Clark CG, Braga GB, Shaw JJ. Short report: molecular characterization of Blastocystis obtained from members of the indigenous Tapirapé ethnic group from the Brazilian Amazon region, Brazil. Am J Trop Med Hyg. 2011;85:1050–3.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Melo GB, Paula FM, Malta FM, Maruta CW, Criado PR, Castilho VLP, et al. Identification of Blastocystis subtypes in clinical stool samples from Sao Paulo City, Brazil. Parasitol Open. 2017;3:1–6.View ArticleGoogle Scholar
  50. Hoffman WA, Pons JA, Janer JL. The sedimentation concentration method in schistosomiasis mansoni. P R J Publ Health Trop Med. 1934;9:283–91.Google Scholar
  51. Zerpa LR, Huicho L, Naquira C. Espinoza I. A simplified culture method for Blastocystis hominis. Ver Mex Patol Clin. 2000;47:17–9.Google Scholar
  52. Böhm-Gloning B, Knobloch J, Walderich B. Five subgroups of Blastocystis hominis from symptomatic and asymptomatic patients revealed by restriction site analysis of PCR-amplified 16S-like rDNA. Trop Med Int Health. 1997;2:771–8.Google Scholar
  53. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725–9.View ArticlePubMedPubMed CentralGoogle Scholar
  54. Huelsenbeck JP, Ronquist R. Bayesian analysis of molecular evolution using MrBayes. In: Nielsen R, editor. Statistical methods in molecular evolution. New York: Springer; 2005. p. 183–232.View ArticleGoogle Scholar
  55. Guindon S, Gascuel O. PhyML: A simple, fast and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 2003;52:696–704.View ArticlePubMedGoogle Scholar
  56. Posada D, Buckley TR. Model selection and model averaging in phylogenetics. Advantage of the AIC and Bayesian approaches over likelihood ratio test. Syst Biol. 2004;53:793–808.View ArticlePubMedGoogle Scholar
  57. Nylander JAA. MrModeltest 2.3. Program distributed by the author. Sweden: Evolutionary Biology Centre, Uppsala University; 2004.Google Scholar
  58. Hasegawa M, Iida Y, Yano T, Takaiwa F, Iwabuchi M. Phylogenetic relationships among eukaryotic kingdoms inferred from ribosomal RNA sequences. J Mol Evol. 1985;22:32–8.View ArticlePubMedGoogle Scholar
  59. Leipe DD, Tong SM, Goggin CL, Slemenda SB, Pieniazek NJ, Sogin ML. 16S-like rDNA sequences from Developayella elegans, Labyrinthuloides haliotidis, and Proteromonas lacerate confirm that the stramenopiles are a primarily heterotrophic group. Eur J Protistol. 1996;32:449–58.View ArticleGoogle Scholar
  60. Silberman JD, Sogin ML, Leipe DD, Clark CG. Human parasite finds taxonomic home. Nature. 1996;4:380-98.Google Scholar
  61. Yoshikawa H, Wu Z, Kimata I, Iseki M, Ali IK, Hossain MB, et al. Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries. Parasitol Res. 2004;92:22–9.View ArticlePubMedGoogle Scholar
  62. Souppart L, Moussa H, Cian A, Sanciu G, Poirier P, El Alaoui H, et al. Subtype analysis of Blastocystis isolates from symptomatic patients in Egypt. Parasitol Res. 2010;106:505–11.View ArticlePubMedGoogle Scholar
  63. Meloni D, Sanciu G, Poirier P, El Alaoui H, Chabé M, Delhaes L, et al. Molecular subtyping of Blastocystis sp. isolates from symptomatic patients in Italy. Parasitol Res. 2011;109:613–9.View ArticlePubMedGoogle Scholar
  64. Fouad SA, Basyoni MM, Fahmy RA, Kobaisi MH. The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome. Arab J Gastroenterol. 2011;12:194–200.View ArticlePubMedGoogle Scholar
  65. Yoshikawa H, Wu Z, Nagano I, Takahashi Y. Molecular comparative studies among Blastocystis isolates obtained from humans and animals. J Parasitol. 2003;89:585–94.Google Scholar
  66. Scicluna SM, Tawari B, Clark CGDNA. Barcoding of Blastocystis. Protist. 2006;157:77–85.View ArticlePubMedGoogle Scholar
  67. Stensvold R, Brillowska-Dabrowska A, Nielsen H, Arendrup M. Detection of Blastocystis hominis in unpreserved stool specimens by using polymerase chain reaction. J Parasitol. 2006;92:1081–7.View ArticlePubMedGoogle Scholar
  68. Yan Y, Su S, Lai R, Liao H, Ye J, Li X, Luo X, Chen G. Genetic variability of Blastocystis hominis isolates in China. Parasitol Res. 2006;99:597–601.View ArticlePubMedGoogle Scholar
  69. Vargas-Sanchez GB, Romero-Valdovinos M, Ramirez-Guerrero C, Vargas-Hernandez I, Ramirez-Miranda ME, Martinez-Ocaña J, et al. Blastocystis isolates from patients with irritable bowel syndrome and from asymptomatic carriers exhibit similar parasitological loads, but significantly different generation times and genetic variability across multiple subtypes. PLoS One. 2015;10(4):e0124006.View ArticlePubMedPubMed CentralGoogle Scholar
  70. Wong K, Ng G, Lin R, Yoshikawa H, Taylor M, Tan K. Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res. 2008;102:663–70.View ArticlePubMedGoogle Scholar
  71. Badparva E, Sadraee J, Kheirandish F. Genetic diversity of Blastocystis isolated from cattle in Khorramabad, Iran. Jundishapur J Microbiol. 2015;8(3):e14810.View ArticlePubMedPubMed CentralGoogle Scholar
  72. Yoshikawa H, Abe N, Iwasawa M, Kitano S, Nagano I, Wu Z, Takahashi Y. Genomic analysis of Blastocystis hominis strains isolated from two long-term health care facilities. J Clin Microbiol. 2000;38(4):1324–30.PubMedPubMed CentralGoogle Scholar
  73. Helenbrook WD, Shields WM, Whipps CM. Characterization of Blastocystis species infection in humans and mantled howler monkeys, Alouatta palliate aequatorialis, living in close proximity to one another. Parasitol Res. 2015;114(7):2517–25.View ArticlePubMedGoogle Scholar
  74. Bart A, Wentink-Bonnema EMS, Gilis H, Verhaar N, Wassenaar CJA, Vugt VM, et al. Diagnosis and subtype analysis of Blastocystis sp. in 442 patients in a hospital setting in the Netherlands. BMC Infect Dis. 2013;13:389.View ArticlePubMedPubMed CentralGoogle Scholar
  75. Coskun A, Malatyali E, Ertabaklar H, Yasar M B, Karaoglu A O, Ertug S. Blastocystis in ulcerative colitis patients: Genetic Diversity and analysis of laboratory findings. Asian Pac J Trop Med. 2016;9(9):916-9.Google Scholar
  76. Badparva E, Pournia Y, Fallahi SH. Prevalence of Blastocytis hominis in Lorstan province, west of Iran. Asian J Biol Sci. 2012;5(2):157–61.Google Scholar
  77. Roberts T, Stark D, Harkness J, Ellis J. Subtype distribution of Blastocystis isolates identified in a Sydney population and pathogenic potential of Blastocystis. Eur J ClinMicrobiol. 2013;32(3):335–43.Google Scholar
  78. Forsell J, Granlund M, Stensvold C, Clark C, Evengard B. Subtype analysis of Blastocystis isolates in Swedish patients. Eur J ClinMicrobiol Infect Dis. 2012;31:1689–96.View ArticleGoogle Scholar
  79. Özyurt M, Kurt Ö, Mølbak K, Nielsen HV, Haznedaroglu T, Stensvold CR. Molecular epidemiology of Blastocystis infections in Turkey. Parasitol Int. 2008;57(3):300–6.View ArticlePubMedGoogle Scholar
  80. Jones MS, Whipps CM, Ganac RD, Hudson NR, Boroom K. Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res. 2009;104(2):341–5.View ArticlePubMedGoogle Scholar
  81. Rene BA, Stensvold CR, Badsberg JH, Nielsen HV. Subtype analysis of Blastocystis isolates from Blastocystis cyst excreting patients. Am J Trop Med Hyg. 2009;80:588–92.PubMedGoogle Scholar
  82. Stensvold CR, Christiansen DB, Olsen KE, Nielsen HV. Blastocystis sp. subtype 4 is common in Danish Blastocystis-positive patients presenting with acute diarrhea. Am J Trop Med Hyg. 2011;84:883–5.View ArticlePubMedPubMed CentralGoogle Scholar
  83. Poirier P, Wawrzyniak I, Albert A, El Alaoui H, Delbac F, Livrelli V. Development and evaluation of a real-time PCR assay for detection and quantification of Blastocystis parasites in human stool samples: prospective study of patients with hematological malignancies. J Clin Microbiol. 2011;49:975–83.View ArticlePubMedPubMed CentralGoogle Scholar
  84. Dominguez-Márquez MV, Guna R, Muñoz C, Gómez-Muñoz MT, Borrás R. High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain). Parasitol Res. 2009;105:949–55.View ArticlePubMedGoogle Scholar
  85. Ramirez JD, Sanchez LV, Bautista DC, Corredor AF, Florez AC, Stensvold CR. Blastocystis subtypes detected in humans and animals from Colombia. Infect Genet Evol. 2014;22:223–8.View ArticlePubMedGoogle Scholar
  86. Ramírez JD, Sánchez A, Hernández C, Flórez C, Bernal MC, Giraldo JC, et al. Geographic distribution of human Blastocystis subtypes in South America. Infect Genet Evol. 2016;41:32–5.View ArticlePubMedGoogle Scholar
  87. Yoshikawa H, Abe N, PCR-based WZ. Identification of zoonotic isolates of Blastocystis from mammals and birds. Microbiology. 2004;150:1147–51.View ArticlePubMedGoogle Scholar
  88. Taamasri P, Mungthin M, Rangsin R, Tongupprakarn B, Areekul W, Leelayoova S. Transmission of intestinal blastocystosis related to the quality of drinking water. Southeast Asian J Trop Med Public Health. 2000;31:112–7.PubMedGoogle Scholar
  89. Yoshikawa H, Wu Z, Pandey K, Pandey BD, Sherchand JB, Yanagi T, Kanbara H. Molecular characterization of Blastocystis isolates from children and rhesus monkeys in Kathmandu, Nepal. Vet Parasitol. 2009;160:295–300.View ArticlePubMedGoogle Scholar
  90. Noel C, Dufernez F, Gerbod D, Edgcomb VP, Delgado-Viscogliosi P, Ho LC, et al. Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol. 2005;43(1):348–55.View ArticlePubMedPubMed CentralGoogle Scholar
  91. Eroglu F, Koltas IS. Evaluation of the transmission mode of B. hominis by using PCR method. Parasitol Res. 2010;107:841–5.View ArticlePubMedGoogle Scholar
  92. Baldursson S, Karanis P. Waterborne transmission of protozoan parasites: review of worldwide outbreaks - an update 2004–2010. Water Res. 2011;45:6603–14.View ArticlePubMedGoogle Scholar
  93. Londoño-Franco AL, Loaiza-Herrera J, Lora-Suárez FM, Gómez-Marín JE. Blastocystis sp. frequency and sources among children from 0 to 5 years of age attending public day care centers in Calarcá, Colombia. Biomedica. 2014;34(2):218–27.View ArticlePubMedGoogle Scholar
  94. Khalili B, Imani R, Boostani S. Intestinal parasitic infections in chronic psychiatric patients in Sina hospital Shahre-Kord, Iran. Jundishapur J Microbiol. 2013;6(3):252–5.Google Scholar
  95. Dogruman-Al F, Dagci H, Yoshikawa H, Kurt O, Demirel MA. Possible link between subtype 2 and asymptomatic infections of Blastocystis hominis. Parasitol Res. 2008;103(3):685–9.View ArticlePubMedGoogle Scholar
  96. Roberts T, Stark D, Harkness J, Ellis J. Update on the pathogenic potential and treatment options for Blastocystis sp. Gut Pathog. 2014;6:17.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement